H7N9 avian influenza virus lysis vaccine (Tianyuan bio-pharm)
H7N9禽流感病毒裂解疫苗（浙江天元生物）
Report date: 2022/07/15 15:58:56
Base Information
Drug NameH7N9 avian influenza virus lysis vaccine (Tianyuan bio-pharm)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A